The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) convened its 4th annual meeting on December 7-8, 2020. The two-day virtual conference included a comprehensive series of expert speakers and panels that shared the latest research, knowledge, and best practices in the field. The theme, Forging the New Frontier of Lung Cancer, highlighted current and future lung cancer care and control initiatives, across the continuum from screening to survivorship. The ACS NLCRT leveraged the unique nature of the virtual conference and encouraged broad participation from ACS NLCRT members and the greater lung cancer community. With over 800 registrants and more than 600 attendees participating in the virtual meeting at any time over the two-day period, we considered the meeting a great success. The conference was divided into eight major sessions with action-oriented panels.
Explore More
Cancer Statistics Center
The ACS’ Cancer Statistics Center website gives the user an opportunity to explore, interact with, and share cancer statistics.
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Accelerating Uptake of Lung Cancer Screening Summit Executive Summary
The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) held its inaugural summit on Accelerating Uptake of Lung Cancer Screening on July 19-20, 2022, in Washington, DC. Increasing lung cancer screening has long been a priority of the NLCRT and its members. The goal of the summit was to accelerate the uptake of lung cancer screening by creating a shared understanding of the current state of screening, identifying key challenges and barriers, and developing and prioritizing strategies to build a comprehensive framework that engages key partners with actionable recommendations.